Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,845,014
-$1,429,479 QoQ
Shares Held
229,374
-12.7% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#72
of 314 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Redmile Group, LLC holds $1,454,356,867 across 35 Biotechnology names. XENE ranks #23 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
4,311,092 | $237,110,060 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
632,005 | $234,897,298 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
3,945,920 | $129,110,502 | |
| 4 | IMNM |
Immunome Inc.
|
4,911,590 | $104,076,592 | |
| 5 | NRIX |
Nurix Therapeutics, Inc.
|
4,073,787 | $98,830,072 | |
| 6 | ABSI |
Absci Corp
|
6,739,675 | $78,112,833 | |
| 7 | ANNX |
Annexon, Inc.
|
11,869,877 | $67,776,997 | |
| 8 | RGNX |
REGENXBIO Inc.
|
4,368,804 | $52,338,271 |
All Filings in XENE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,845,014 | 229,374 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,274,493 | 262,674 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,000,591 | 133,882 | Shares | Sole | 2026-02-17 | |
| 2023-09-30 | $14,332,442 | 419,568 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $43,138,326 | 1,120,476 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $47,451,527 | 1,325,832 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $93,071,124 | 2,360,414 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $85,579,165 | 2,370,614 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $49,868,844 | 1,639,344 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||